Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 11
Submit an article Journal homepage
75
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of Vinblastine, Bleomycin, Methotrexate (VBM) Combination Chemotherapy with Involved Field Radiotherapy in Early Stage (I-IIA) Hodgkin Disease Patients

G. Martinelli Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan. Italy
,
E. Cocorocchio Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan. Italy
,
P. C. Saletti Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona. Switzerland
,
R. Orecchia Division of Radiotherapy, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy; Faculty of Medicine, University of Milan, Milan, Italy
,
J. Bernier Division of Radiation Oncology, Ospedale San Giovanni CH-6500 Bellinzona, Switzerland
,
N. Tradati Division of Heud and Neck Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
P. Santoro Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan. Italy
,
C. Robertson Division of Epidemiology, European Institute of Oncology, Via Ripamonti 435. 20141, Milan, Italy
,
F. A. Peccatori Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan. Italy
,
E. Zucci Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona. Switzerland
&
F. Cavalli Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona. Switzerland
 show all
Pages 1919-1923 | Published online: 22 Nov 2010

References

  • Bonfante, V., Viviani, S., Devizzi, L., et al. (2001) "Ten years experience with ABVD plus radiotherapy: subtotal nodal (STN1) vs involved field (IFRT) in early stage Hodgkin's disease (HD)", Proc. Am. Soc. Clin. Oncol. 20, 281a, Abstract 1120.
  • Horning, S.J., Hoppe, R.T., Hancock, S.L., et al. (1988) "Vinblastine, bleomycin and methotrexate: an effective adjuvant in favorable Hodgkin's disease", J. Clin. Oncol. 6(12), 1822–1831.
  • Hancock, S.L., Tucker, M.A. and Hoppe, R.T. (1993) "Factors affecting late mortality from heart disease after treatment of Hodgkin's disease", J. Am. Med. Ass. 270(16). 1949–1955.
  • Horning, Si., Hoppe, R.T., Hason, J., et al. (1997) "Stanford-Kaiser permanent GI study for clinical stage Ito IIA Hodgkin's disease: subtotal lymphoid irradiation vs vinblastine, methotrexate and bleomycin chemotherapy and regional irradiation", J. Clin. Oncol. 15, 1736–1744.
  • Bates, NP., Williams, MV., Bessel, EM., et al. (1994) "Efficacy and toxicity of vinblastine, bleomycin and methotrexate with involved field radiotherapy in clinical stage la and ha Hodgking's disease: a British National Lymphoma Investigation Pilot Study", J. Clin. Oncol. 12(2), 288–296.
  • Gobbi, P., Pieresca, C., Frassoldati, A., et al. (1996) "Vinblastine, bleomycin and methotrexate chemotherapy plus extended field radiotherapy in early, favorable presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi experience", .1. Clin. Oncol. 14(2), 527–533.
  • Duhmke, E., Diehl, V., Loeffler, M., etal. (1996) "Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs 40 Gy extended field radiotherapy alone", int. J. Radial. Oncol. Biol. Phys. 36(2), 305 —310.
  • Cheson, B.D., Horning, S.J., Coiffier, B., et al. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas", J. Clin. Oncol. 17(4), 1244-1253. 191 Kaplan, E.L. and Meier, P. (1958) "Non parametric estimation from incomplete observations", J. Am. Stat. Assoc. 53, 457-481. 1101 Cox, D.R. (1972) "Regression model and life tables", 1 R. Stat. Soc. 34, 187.
  • Noordijk, EM., Carde, P., Mandard, A.M., et al. (1994) "Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early stage Hodgkin disease. EORTC Lymphoma Cooperative Groupe Pierre-et-Marie-Curie", Ann. Oncol. 5(2), 107–112.
  • Einhorn, L., Kraus, M., Hornback, N., et al. (1976) "Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell cancer", Cancer 37(5), 2458–2464.
  • Horning, S.J., Adhikari, A., Rizk, N., et al. (1994) "Effect of treatment for Hodgkin's disease on pulmonary function: results of prospective study", J. CIO'. Oncol. 12(2), 297–305.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.